Midea Completes Acquisition of Esaote, Aiming to Enhance Global Healthcare
Midea's Strategic Move in Healthcare
On October 9, 2026, Esaote S.p.A., a leader in the medical imaging field, announced the completion of its acquisition by Midea Group, a renowned Chinese global technology corporation. This acquisition marks a pivotal moment for both companies, as it enables Midea to fortify its operations in the healthcare sector and enhance the synergy between its healthcare division and Esaote.
Esaote will continue to function as an independent entity within Midea’s Healthcare Division, maintaining its headquarters in Genoa, Italy, and carrying on its operations in research, development, and medical equipment manufacturing. The strategic partnership will offer Esaote the opportunity to access a wider technological ecosystem, leverage complementary imaging capabilities, and broaden innovation platforms to accelerate growth and shorten product development cycles.
According to Esaote's CEO, Franco Fontana, this new chapter is an exciting time for the company. He highlighted that through Midea’s industry reach and resources, Esaote will enhance its position in the global healthcare arena, satisfying ever-evolving clinical and scientific needs. The announcement emphasized the potential for collaborative ventures that promise to lead advancements in medical technologies vital for healthcare improvement.
Expansion of Product Offerings
Midea's extensive product lineup, which includes radiology systems, high-field MRI, computed tomography, and digital angiography, is expected to complement Esaote's specialty in ultrasound, open MRI systems, and medical IT solutions. This integration will create strong synergies, enabling a broader range of options for clients, and will enhance access to high-definition diagnostic technologies across international markets.
In a statement from Jinlei Chen, president of Midea Healthcare Division, he expressed that acquiring Esaote aligns with their strategic vision in expanding Midea Healthcare's presence globally. He remarked on Esaote's exceptional expertise and strong innovative capacities, stating that this collaboration will facilitate significant advancements in healthcare delivery.
Commitment to Innovation
Likewise, Eric Wang, Executive Chairman of the Midea Group, emphasized the importance of this acquisition in their strategy to enhance health technology capabilities. He stated that the close relationship between Midea and Esaote will provide a diverse and comprehensive imaging solution, broadening choices for healthcare providers and ensuring better access to essential diagnostic innovations on a global scale.
This transformative deal sets a promising trajectory for both organizations. With Esaote operating in over 100 countries and achieving a revenue of €267 million in 2025, bolstered by 70% from international markets, the future looks bright.
Profiles of the Companies
About Esaote: Founded in Italy, Esaote is renowned for medical imaging innovation. It ranks among the top ten manufacturers of ultrasound devices and dedicated MRI systems worldwide. About 20% of its workforce is engaged in R&D, allocating approximately 12% of annual revenue to this critical area.
About Midea Group: Headquartered in Shunde, Foshan, Guangdong, Midea is a global technology powerhouse established in 1968, which has expanded into sectors such as home automation, industrial technology, health, and smart logistics. The company reported a worldwide revenue of approximately $64.3 billion in 2025 and is listed on the Shenzhen Stock Exchange and Hong Kong Stock Exchange. Midea has recently established the Midea Healthcare division focusing on intelligent medical imaging solutions.
In conclusion, as Midea integrates Esaote into its fold, the acquisition not only represents a financial investment but also reflects a commitment to advancing healthcare through technological innovation and enhanced product offerings. The collaboration will pave the way for new growth opportunities and advancements in health technology for years to come.